Literature DB >> 14963606

Follow-up study of morphology and cardiac function in rats undergoing induction of supravalvular aortic stenosis.

Henrique Barbosa Ribeiro1, Katashi Okoshi, Antonio Carlos Cicogna, Edson Antonio Bregagnollo, Maria Aparecida Marchesan Rodrigues, Carlos Roberto Padovani, Flávio Ferrari Aragon, Elenize Jamas, Marina Politi Okoshi.   

Abstract

OBJECTIVE: To characterize the follow-up of an experimental model of left ventricular hypertrophy (LVH) induced by supravalvular ascending aortic stenosis in young rats.
METHODS: Wistar rats were submitted to thoracotomy and aortic stenosis was created by placing a clip on the ascending aorta (AoS group, n=12). Age-matched control animals underwent a sham operation (C group, n=12). Cardiac function was analysed by echocardiograms performed 6, 12, and 21 weeks after aortic banding. Myocardial morphological features and myocardial hydroxyproline concentration (HOP) were evaluated 2, 6, 12, and 21 weeks after surgery in additional animals.
RESULTS: Aortic banding promoted early concentric LVH and a progressive increase in HOP. Under light microscopy, we observed myocyte hypertrophy and wall thickening of the intramural branches of the coronary arteries due to medial hypertrophy. Cardiac function was supranormal after 6 weeks (percentage of fractional shortening - EAo6: 70.3 +/- 10.8; C6: 61.3 +/- 5.4; p<0.05), and depressed in the last period. Diastolic dysfunction was detected after 12 weeks (ratio of early-to-late filling velocity - EAo12: 4.20 +/- 3.25; C12: 1.61 +/- 0.16; p<0.05).
CONCLUSION: Ascending aortic stenosis promotes concentric LVH with myocardial fibrosis and minimal histological changes. According to the period of evaluation, cardiac function may be improved, normal, or depressed. The model is suitable and useful for studies on pathophysiology and treatment of the different phases of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963606     DOI: 10.1590/s0066-782x2003001400003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  4 in total

1.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

2.  Enhanced Redox State and Efficiency of Glucose Oxidation With miR Based Suppression of Maladaptive NADPH-Dependent Malic Enzyme 1 Expression in Hypertrophied Hearts.

Authors:  Ryan Lahey; Andrew N Carley; Xuerong Wang; Carley E Glass; Kevin D Accola; Scott Silvestry; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2018-01-31       Impact factor: 17.367

3.  Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism.

Authors:  Loreta Casquel De Tomasi; Dijon Henrique Salomé Campos; Paula Grippa Sant'Ana; Katashi Okoshi; Carlos Roberto Padovani; Gilson Masahiro Murata; Son Nguyen; Stephen C Kolwicz; Antonio Carlos Cicogna
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

4.  Congestive heart failure model representing aortic banding induced hypertrophy: A study to analyse extent of pressure overload and alteration in myocardial structure and function.

Authors:  Arti Patel; Darshna Patel
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.